Cardio Diagnostics Holdings, Inc. Other Executive Compensation Disclosures
Every other executive-compensation XBRL fact the company filed (policies, award timing, footnotes, adjustments), newest first. Long text is shortened; the filing has the full text.
- 2026-08-07: Disclosure Rule10b51Arr Adopted; Period 2026-04-01..2026-06-30; Value No.
- 2026-08-07: Disclosure Non Rule10b51Arr Adopted; Period 2026-04-01..2026-06-30; Value No.
- 2026-08-07: Disclosure Rule10b51Arr Terminated; Period 2026-04-01..2026-06-30; Value No.
- 2026-08-07: Disclosure Non Rule10b51Arr Terminated; Period 2026-04-01..2026-06-30; Value No.
| Filed | Disclosure | Qualifiers | Period | Value |
|---|---|---|---|---|
| 2026-08-07 10-Q | Rule10b51Arr Adopted | 2026-04-01..2026-06-30 | No | |
| 2026-08-07 10-Q | Non Rule10b51Arr Adopted | 2026-04-01..2026-06-30 | No | |
| 2026-08-07 10-Q | Rule10b51Arr Terminated | 2026-04-01..2026-06-30 | No | |
| 2026-08-07 10-Q | Non Rule10b51Arr Terminated | 2026-04-01..2026-06-30 | No | |
| 2026-08-05 DEF 14A | Insider Trading Policies Proc Adopted | 2025-01-01..2025-12-31 | Yes | |
| 2026-08-05 DEF 14A | Award Timing MNPI Disclosure | 2025-01-01..2025-12-31 | Our equity-based incentive awards are designed to align our interests and the interests of our stockholders with those of our employees and consultants, including our Named Executive Officers. The Board or Compensation Committee is responsible for approving equity grants. We grant equity awards to e… | |
| 2026-08-05 DEF 14A | Award Timing Method | 2025-01-01..2025-12-31 | We grant equity awards to employees annually upon achieving Company and personal milestones. Annual awards are typically granted in the first quarter of each year. Generally, our equity awards granted to our Named Executive Officers vest immediately. | |
| 2026-08-05 DEF 14A | Award Timing MNPI Considered | 2025-01-01..2025-12-31 | Yes | |
| 2026-08-05 DEF 14A | Award Timing How MNPI Considered | 2025-01-01..2025-12-31 | The Board and Compensation Committee do not take material nonpublic information into account when determining the timing and terms of equity-based awards, and the Company does not time the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation. … | |
| 2026-08-05 DEF 14A | MNPI Disclosure Timed For Compensation Val | 2025-01-01..2025-12-31 | No | |
| 2026-05-15 10-Q | Rule10b51Arr Adopted | 2026-01-01..2026-03-31 | No | |
| 2026-05-15 10-Q | Non Rule10b51Arr Adopted | 2026-01-01..2026-03-31 | No | |
| 2026-05-15 10-Q | Rule10b51Arr Terminated | 2026-01-01..2026-03-31 | No | |
| 2026-05-15 10-Q | Non Rule10b51Arr Terminated | 2026-01-01..2026-03-31 | No | |
| 2026-03-13 10-K | Rule10b51Arr Adopted | 2025-10-01..2025-12-31 | No | |
| 2026-03-13 10-K | Non Rule10b51Arr Adopted | 2025-10-01..2025-12-31 | No | |
| 2026-03-13 10-K | Rule10b51Arr Terminated | 2025-10-01..2025-12-31 | No | |
| 2026-03-13 10-K | Non Rule10b51Arr Terminated | 2025-10-01..2025-12-31 | No | |
| 2026-03-13 10-K | Insider Trading Policies Proc Adopted | 2025-01-01..2025-12-31 | Yes | |
| 2025-11-12 10-Q | Rule10b51Arr Adopted | 2025-01-01..2025-09-30 | No | |
| 2025-11-12 10-Q | Non Rule10b51Arr Adopted | 2025-01-01..2025-09-30 | No | |
| 2025-11-12 10-Q | Rule10b51Arr Terminated | 2025-01-01..2025-09-30 | No | |
| 2025-11-12 10-Q | Non Rule10b51Arr Terminated | 2025-01-01..2025-09-30 | No | |
| 2025-09-04 DEF 14A | Insider Trading Policies Proc Adopted | 2024-01-01..2024-12-31 | Yes | |
| 2025-09-04 DEF 14A | Award Timing MNPI Disclosure | 2024-01-01..2024-12-31 | Our equity-based incentive awards are designed to align our interests and the interests of our stockholders with those of our employees and consultants, including our Named Executive Officers. The Board or Compensation Committee is responsible for approving equity grants. We grant equity awards to e… | |
| 2025-09-04 DEF 14A | Award Timing Method | 2024-01-01..2024-12-31 | We grant equity awards to employees annually upon achieving Company and personal milestones. Annual awards are typically granted in the first quarter of each year. Generally, our equity awards granted to our Named Executive Officers vest immediately. | |
| 2025-09-04 DEF 14A | Award Timing MNPI Considered | 2024-01-01..2024-12-31 | Yes | |
| 2025-09-04 DEF 14A | Award Timing How MNPI Considered | 2024-01-01..2024-12-31 | The Board and Compensation Committee do not take material nonpublic information into account when determining the timing and terms of equity-based awards, and the Company does not time the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation. … | |
| 2025-09-04 DEF 14A | MNPI Disclosure Timed For Compensation Val | 2024-01-01..2024-12-31 | No | |
| 2025-08-14 10-Q | Rule10b51Arr Adopted | 2025-04-01..2025-06-30 | No | |
| 2025-08-14 10-Q | Non Rule10b51Arr Adopted | 2025-04-01..2025-06-30 | No | |
| 2025-08-14 10-Q | Rule10b51Arr Terminated | 2025-04-01..2025-06-30 | No | |
| 2025-08-14 10-Q | Non Rule10b51Arr Terminated | 2025-04-01..2025-06-30 | No | |
| 2025-05-15 10-Q | Rule10b51Arr Adopted | 2025-01-01..2025-03-31 | No | |
| 2025-05-15 10-Q | Non Rule10b51Arr Adopted | 2025-01-01..2025-03-31 | No | |
| 2025-05-15 10-Q | Rule10b51Arr Terminated | 2025-01-01..2025-03-31 | No | |
| 2025-05-15 10-Q | Non Rule10b51Arr Terminated | 2025-01-01..2025-03-31 | No | |
| 2025-03-20 10-K | Rule10b51Arr Adopted | 2024-01-01..2024-12-31 | No | |
| 2025-03-20 10-K | Non Rule10b51Arr Adopted | 2024-01-01..2024-12-31 | No | |
| 2025-03-20 10-K | Rule10b51Arr Terminated | 2024-01-01..2024-12-31 | No | |
| 2025-03-20 10-K | Non Rule10b51Arr Terminated | 2024-01-01..2024-12-31 | No | |
| 2025-03-20 10-K | Insider Trading Policies Proc Adopted | 2024-01-01..2024-12-31 | Yes | |
| 2024-11-13 10-Q | Rule10b51Arr Adopted | 2024-07-01..2024-09-30 | No | |
| 2024-11-13 10-Q | Non Rule10b51Arr Adopted | 2024-07-01..2024-09-30 | No | |
| 2024-11-13 10-Q | Rule10b51Arr Terminated | 2024-07-01..2024-09-30 | No | |
| 2024-11-13 10-Q | Non Rule10b51Arr Terminated | 2024-07-01..2024-09-30 | No | |
| 2024-08-12 10-Q | Rule10b51Arr Adopted | 2024-04-01..2024-06-30 | No | |
| 2024-08-12 10-Q | Non Rule10b51Arr Adopted | 2024-04-01..2024-06-30 | No | |
| 2024-08-12 10-Q | Rule10b51Arr Terminated | 2024-04-01..2024-06-30 | No | |
| 2024-08-12 10-Q | Non Rule10b51Arr Terminated | 2024-04-01..2024-06-30 | No | |
| 2024-05-15 10-Q | Rule10b51Arr Adopted | 2024-01-01..2024-03-31 | No | |
| 2024-05-15 10-Q | Non Rule10b51Arr Adopted | 2024-01-01..2024-03-31 | No | |
| 2024-05-15 10-Q | Rule10b51Arr Terminated | 2024-01-01..2024-03-31 | No | |
| 2024-05-15 10-Q | Non Rule10b51Arr Terminated | 2024-01-01..2024-03-31 | No | |
| 2024-04-01 10-K | Rule10b51Arr Adopted | 2023-01-01..2023-12-31 | No | |
| 2024-04-01 10-K | Non Rule10b51Arr Adopted | 2023-01-01..2023-12-31 | No | |
| 2024-04-01 10-K | Rule10b51Arr Terminated | 2023-01-01..2023-12-31 | No | |
| 2024-04-01 10-K | Non Rule10b51Arr Terminated | 2023-01-01..2023-12-31 | No |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |